Decentralized clinical trials startup Curebase has laid off many employees as the company scraps its clinical operations business to focus on software, per a Thursday LinkedIn post from founder and CEO Tom Lemberg.
Curebase’s downsizing and narrowed ambitions come as the decentralized and hybrid clinical trials…
Click here to view original post
